Filing Date Form TypeDescription     
     
Data pager
 Page 1 of 17, items 1 to 13 of 214.
2023-05-1210-QQuarterly report [Sections 13 or 15(d)]Acc-no: 0001213900-23-038952 (34 Act)  Size: 3 MB
2023-05-114Statement of changes in beneficial ownership of securitiesAcc-no: 0001415889-23-007766 Size: 6 KB
2023-05-104Statement of changes in beneficial ownership of securitiesAcc-no: 0001415889-23-007710 Size: 6 KB
2023-05-104Statement of changes in beneficial ownership of securitiesAcc-no: 0001415889-23-007706 Size: 4 KB
2023-05-038-KCurrent report, items 2.02 and 9.01 Acc-no: 0001213900-23-035978 (34 Act)  Size: 291 KB
2023-05-01DEF 14AOther definitive proxy statementsAcc-no: 0001213900-23-034173 (34 Act)  Size: 5 MB
2023-03-2310-KAnnual report [Section 13 and 15(d), not S-K Item 405]Acc-no: 0001213900-23-022355 (34 Act)  Size: 4 MB
2023-02-10SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individualsAcc-no: 0001493152-23-004213 (34 Act)  Size: 81 KB
2023-02-098-KCurrent report, items 2.02 and 9.01 Acc-no: 0001213900-23-009738 (34 Act)  Size: 326 KB
2023-02-034Statement of changes in beneficial ownership of securitiesAcc-no: 0001415889-23-001898 Size: 4 KB
2023-02-014Statement of changes in beneficial ownership of securitiesAcc-no: 0001415889-23-001704 Size: 6 KB
2023-01-113Initial statement of beneficial ownership of securitiesAcc-no: 0001415889-23-000828 Size: 5 KB
2023-01-113Initial statement of beneficial ownership of securitiesAcc-no: 0001415889-23-000820 Size: 4 KB


Sensus Healthcare's SRT Treatment Shows Promise in Treating Cutaneous Mast Cell Tumors Among Pet Patients
05/17/2023 12:00 PM

BOCA RATON, Fla, May 17, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare Inc. (Nasdaq:SRTS), the leading manufacturer of advanced medical devices for non-surgical skin cancer and keloid scar treatment, is announcing that its superficial radiation therapy SRT-100 system has shown promising results treating Cutaneous Mast Cell Tumors (MCTs) in pets. This new limited study, just published in the Journal of the American Veterinary Medical Association, demonstrates the potential effectiveness and safety of SRT treatment.


Sensus Healthcare Reports First Quarter 2023 Financial Results
05/03/2023 8:05 PM

Lower demand for SRT systems reflects the impact of inflation on dermatologists’ cash flow from fewer elective aesthetic procedures and higher operating costs


Sensus Healthcare to Host First Quarter 2023 Financial Results and Business Update Conference Call on Wednesday, May 3, 2023
04/25/2023 8:05 PM

BOCA RATON, Fla. , April 25, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Wednesday, May 3, 2023 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter of 2023. In addition, management will provide a business update and a discussion on recent and upcoming milestones.


Sensus Healthcare announces the Sensus Cloud™; Unveils New Features at American Academy of Dermatology (AAD) Annual Meeting in New Orleans March 17-19
03/16/2023 8:09 PM

New comprehensive asset and EMR management feature allows users to collect real-time information from the device to manage and maintain multiple machines with Chat GPT
New comprehensive asset and EMR management feature allows users to collect real-time information from the device to manage and maintain multiple machines with Chat GPT

Sensus Healthcare Fourth Quarter 2022 Financial Results Include Quarterly Revenues of $13.1 Million
02/09/2023 9:05 PM

Full-year revenues increased 65% to $44.5 million


Sensus Healthcare to Host Fourth Quarter 2022 Financial Results and Business Update Conference Call on February 9, 2023
02/01/2023 9:05 PM

BOCA RATON, Fla., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, February 9, 2023 at 4:30 p.m. Eastern time to discuss the financial results for the fourth quarter and full year 2022. In addition, management will provide a business update and a discussion on recent and upcoming milestones.


Sensus Healthcare Announces Senior Management Appointments and Promotions
01/09/2023 1:00 PM

BOCA RATON, Fla, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, is pleased to announce the following promotions and appointments to its management team:


Sensus Healthcare Announces Preliminary Fourth Quarter 2022 Revenues
01/05/2023 9:05 PM

Fourth quarter revenues to exceed $13 million; full year revenues to exceed $44 million, representing growth of 60%


Sensus Healthcare Reports Third Quarter 2022 Financial Results
11/03/2022 8:05 PM

Profitability continues with revenues up 64% to $9.0 million, diluted EPS of $0.11 compares with $0.01 a year ago


Sensus Healthcare to Host Third Quarter 2022 Financial Results and Business Update Conference Call on November 3, 2022
10/27/2022 12:00 PM

BOCA RATON, Fla., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, November 3, 2022 at 4:30 p.m. Eastern time to discuss the financial results for the third  quarter of 2022. In addition, management will provide a business update and a discussion on recent and upcoming milestones.


Sensus Healthcare Introduces Silk™ Laser Hair Removal System
10/20/2022 3:56 PM

Only portable hair removal laser system with blended wavelengths for all skin phototypes to be launched at the Fall Clinical Dermatology Conference
Only portable hair removal laser system with blended wavelengths for all skin phototypes to be launched at the Fall Clinical Dermatology Conference

Sensus Healthcare to Present at the H.C. Wainwright 24th Annual Global Investment Conference
09/09/2022 12:00 PM

BOCA RATON, Fla., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments for oncological and non-oncological conditions, announces that management will present a company overview at the H.C. Wainwright 24th Annual Global Investment Conference being held September 12-14, 2022.  The hybrid format includes in-person meetings in New York City and will be holding one-on-one meetings.  A webcast of the presentation will be available on-demand beginning September 12, 2022 at 7:00 a.m. Eastern time on the investors section of Sensus Healthcare’s website or at this link.


Sensus Healthcare Adds Dr. Mohammad K. Khan to Medical Advisory Board
09/07/2022 12:00 PM

Addition of World-Renowned Radiation Oncologist Deepens Pool of Expertise
Addition of World-Renowned Radiation Oncologist Deepens Pool of Expertise

Sensus Healthcare Launches Upgrade to its SRT-100 Vision System with New State-of-the-Art Ultrasound Capabilities
08/09/2022 8:25 PM

Includes a new ergonomic probe to operate in ideal MHz range to view all layers of skin
Includes a new ergonomic probe to operate in ideal MHz range to view all layers of skin

Sensus Healthcare Second Quarter 2022 Financial Results Feature Revenue Growth of 124%
08/04/2022 8:05 PM

Diluted EPS of $0.21 compares with $(0.02) for the year-ago quarter 
Affirms expectations for full-year profitability


Sensus Healthcare Takes Order for 10 TransDermal Infusion Systems™ Supporting Hair Enhancement Centers Expansion Along with U.SK Under Skin’s Hair-Health Serum
07/27/2022 12:00 PM

BOCA RATON, Fla., July 27, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments for oncological and non-oncological conditions, announces the sale of 10 Transdermal Infusion Systems™ to Hair Enhancement Centers (HEC), a rapidly-growing chain of Texas-based hair loss treatment centers. The Systems will be used to non-invasively deliver U.SK Under Skin’s hair-health serum Skin Savers Hair™.  U.SK Under Skin is a subsidiary of privately-held EMS Pharma, the largest pharmaceutical company in Brazil and itself a subsidiary of Grupo NC, one of Brazil’s largest conglomerates.


Sensus Healthcare to Host Second Quarter 2022 Financial Results and Business Update Conference Call on August 4, 2022
07/26/2022 12:00 PM

BOCA RATON, Fla., July 26, 2022 (GLOBE NEWSWIRE) --  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, August 4, 2022 at 4:30 p.m. Eastern time to discuss the financial results for the second quarter of 2022. In addition, management will provide a business update and a discussion on recent and upcoming milestones.


Colorado State University College of Veterinary Medicine and Biomedical Sciences Acquires Second SRT System from Sensus Healthcare
07/20/2022 12:00 PM

Researchers at the Johnson Family Equine Hospital to study superficial radiation therapy in horses following the University’s successful use in companion animals


Correction: Sensus Healthcare to Participate in the H.C. Wainwright Global Investment Conference
05/23/2022 7:56 PM

BOCA RATON, Fla, May 23, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments for oncological and non-oncological conditions, announces that management will be participating in the H.C. Wainwright Global Investment Conference taking place virtually and in-person at the Fontainebleau Miami Beach May 23-26, 2022. 


Sensus Healthcare to Participate in the H.C. Wainwright Global Investment Conference
05/18/2022 8:05 PM

BOCA RATON, Fla, May 18, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments for oncological and non-oncological conditions, announces that management will be participating in the H.C. Wainwright Global Investment Conference taking place virtually and in-person at the Fontainebleau Miami Beach May 23-26, 2022.